Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Operating Expenses | 30,962 | 34,700 | 41,879 | 36,568 | 18,939 |
| Operating Income | -30,962 | -34,700 | -41,879 | -36,568 | -18,939 |
| Other Income | 187 | -14 | -9 | -1,407 | 518 |
| Pre-tax Income | -30,775 | -34,714 | -41,888 | -37,975 | -18,421 |
| Income Tax | N/A | N/A | 16 | 17 | 12 |
| Net Income Continuous | -30,775 | -34,714 | -41,904 | -37,992 | -18,433 |
| Net Income | $-30,775 | $-34,714 | $-41,904 | $-37,992 | $-18,433 |
| EPS Basic Total Ops | -0.50 | -0.83 | -1.19 | -1.42 | -0.96 |
| EPS Basic Continuous Ops | -0.50 | -0.83 | -1.19 | -1.42 | -0.96 |
| EPS Diluted Total Ops | -0.50 | -0.83 | -1.19 | -1.45 | -1.00 |
| EPS Diluted Continuous Ops | -0.50 | -0.83 | -1.19 | -1.42 | -0.96 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -0.83 | -1.19 | -1.22 | -1.00 |
| EBITDA(a) | $-30,897 | $-34,588 | $-41,611 | $-36,328 | $-18,714 |